A Phase I, Randomized, Open-Label, Single-Dose, Three-Way Crossover Study Assessing the Drug-Drug Interaction Between ZX008 (Fenfluramine Oral Solution) and Stiripentol/Clobazam/Valproate in Healthy Subjects

Trial Profile

A Phase I, Randomized, Open-Label, Single-Dose, Three-Way Crossover Study Assessing the Drug-Drug Interaction Between ZX008 (Fenfluramine Oral Solution) and Stiripentol/Clobazam/Valproate in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Jan 2018

At a glance

  • Drugs Fenfluramine (Primary) ; Clobazam; Stiripentol; Valproate
  • Indications Dravet syndrome; Epilepsy; Lennox-Gastaut syndrome; Seizures
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 03 Jan 2018 New trial record
    • 05 Dec 2017 Results presented at the 71st Annual Meeting of the American Epilepsy Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top